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1  Introduction
Health assessment instruments in Chinese medicine 
are developing at a rapid rate[1]. These instruments serve 
as tools that were used by researchers, physicians and 
patients to measure physical, psychological, and social 
well-being of the patients. At their core, health assess-
ment instruments are the most useful tools in clinical trials 
and practice. Instrument development is an essential but 
intermediate step, rather than the ultimate end-goal in 
instrument-related studies.
Currently in China, many Chinese medicine-specific 
instruments that were developed by Chinese medical 
researchers have minimal application in clinical practice, 
compared with comparable questionnaires developed by 
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Western medical researchers, which are common clinical 
tools. The high volume of Chinese medicine instrument 
development as compared to low volume of instrument 
application marks many wasted resources in scientific 
research, and also raises the question of the validity and 
reliability of those Chinese medicinal studies that did not 
utilize health assessment instruments. This study aims to 
explore and analyze the application of health assessment 
instruments in Chinese medicine. 
2  Methods 
2.1  Concepts and terminologies
“Chinese medicine”, “health outcome” and “instrument” 
were defined in the previous study[1]. 
2.2  Search strategies
2.2.1  Source, formula and parameters
Literature searches in China National Knowledge Infra-
structure (CNKI) with the formula of “(AB = ( 量 + 问 +
调查 )*( 表 + 卷 )+ 工具 + 条目 ) and ((SU = 随即对照
试验 + 对照临床试验 + 临床试验 or AB = 随机 + 安
慰 + 描述性 + 观察性 + 前瞻性 + 回顾性 or TI = 随
机 + 安 慰 + 试 验 ) not (SU = 动 物 not SU = 动 物 *
人 ))” were performed. Subject domain was limited to 
within the three sub-libraries of “Chinese medicine”, 
“Chinese pharmacology” and “integrated traditional Chinese 
and Western medicine”, while the date range was “1915 
to 2012”. To trace the applications of those instruments 
in clinical trials, we also retrieved full-texts of 97 articles 
that included health outcome assessment instruments in 
traditional Chinese medicine, as listed in the previous article[1]. 
The last search was performed on January 20th, 2012. 
2.2.2  Inclusion criteria
Literature included must have met the following conditions: 
(1) a study subheading under Chinese medicine research; 
(2) randomized clinical trials, and descriptive or observa-
tional studies that included outcome evaluations. 
2.2.3  Exclusion criteria
Literature was excluded if the study met any of the following 
conditions: (1) non-clinical trials, including animal 
experiments, reviews, systematic reviews, meta-analyses 
and the others; (2) cross-sectional, diagnostic and prognosis 
studies without outcome evaluations; (3) updated revision 
and/or translation of existing instruments; (4) theoretical 
and educational research on instruments; (5) instruments 
that were only mentioned in the background or the introduc-
tion but were not analyzed in discussion; (6) the title of 
instruments used in the study was not mentioned and can 
not be identified; (7) duplicate publications; (8) full-text is 
unobtainable. It must be noted that the 97 instruments in 
Chinese medicine were not excluded by (1) and (2) for the 
purpose of descriptive analyses.
2.2.4  Data management
The steps of data management in this study were performed 
as previously described[1].
3  Results 
3.1  Literature search results
According to the above described procedure, 4 557 records 
were retrieved from the CNKI database. After strict selection 
with the inclusion and exclusion criteria, 2 152 records 
were identified for this study. More than 60 categories 
were involved, including clinical medicine of traditional 
Chinese medicine (50.1%), Chinese medicine neurology and 
psychiatry (21.7%), internal Chinese medicine (13.6%), 
clinical discipline of integrated traditional Chinese and 
Western medicine (4.5%). The instruments mainly focused 
on depression, acupuncture, quality of life (QOL), vascular 
dementia, cerebral apoplexy, insomnia, lumbar disc 
herniation, and coronary heart disease. Involved research 
institutions included Guangzhou University of Chinese 
Medicine (13.2%), Chengdu University of Traditional 
Chinese Medicine (4%), Heilongjiang University of 
Chinese Medicine (3.6%), Guangdong Hospital of 
Traditional Chinese Medicine (3.1%), among others. The 
research involved various funding programs including 
National Basic Research Program of China (973 Program), 
National High-tech Research and Development Program 
(863 Program), State Science and Technology Support 
Program, and Natural Science Foundation of China 
(NSFC). The research volume increased significantly 
every year, with the number of journal articles in the most 
recent 5 years being 197 (2007), 238 (2008), 333 (2009), 
465 (2010) and 502 (2011). The sub-databases included 
China Academic Journal Network Publishing Database 
(CAJD, 50.1%), China Master’s Theses Full-text Database 
(CMFD, 32.1%), China Doctoral Dissertations Full-text 
Database (CDFD, 9.7%) and China Conferences Full-text 
Database (8.1%).
3.2  Application of domestically-developed instruments 
in Chinese medicine
Combining the retrieved electronic copies of the 97 instruments 
in Chinese medicine with various interviews with experts, 
we found that many instruments have been used in clinical 
trials, and basic and theoretical research[2-30].
3.2.1  Application in clinical trials
As shown in Table 1, 14 instruments were used in 29 studies, 
including randomized controlled trials, descriptive studies 
and cross-sectional studies[2-30].
3.2.2  Application in basic and theoretical research
The instruments were mainly used in the following 
aspects. (1) To provide sources for related research reviews 
and expand related research discipline. For example, 
Liu et al[31] considered that the Chinese Quality of Life 
(ChQOL) instrument, a domestic general assessment 
instrument, reflected the characteristics of Chinese medicine 
and Chinese culture. Those characteristics specified by the 
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ChQOL borrowed perspective and served as reference for 
instrument development relevant to Chinese medicine and 
Chinese culture[32-34]. (2) To provide sources for conceptual 
framework of instrument and item pool development. 
For example, the Traditional Chinese Medicine Patient-
Reported Outcome Questionnaire for Breast Cancer[35] and 
Patient-Reported Outcome Efficacy Scale of Traditional 
Chinese Medicine in Coronary Heart Disease[36] listed 
the ChQOL as their source of conceptual framework; 
the Syndrome Element Scale for Diabetic Retinopathy[37] 
and Scale of Living Quality on HIV/AIDS[38] listed the 
ChQOL as the source of item pool; the Health Status 
Scale of Traditional Chinese Medicine[39] served as part 
of the Evaluation Scale System in Xiaoke-associated 
Eye Disease for clinical curative effect[8]. (3) To provide 
methodological cues for similar research. For example, 
the ChQOL instrument provided methods of quality 
determination that were used by Critical Illness Prognosis 
Scoring Scale of Traditional Chinese Medicine[40] and 
Sub-health Symptom Check Scale for College Students[41] 
for reliability and validity evaluation, and for overall quality 
evaluation. Quality of Life Scale for Nasopharyngeal 
Cancer[42] used t-test and analysis of variance to measure 
items, in a similar manner as had been determined by the 
ChQOL instrument. (4) To provide assessment tools for 
scientific research. For example, many instruments, such 
as the Chinese Quality of Life Instrument[31], TCM Syndrome 
Questionnaire of Sub-health State[43], Emotion Rating Scale 
for Ganzangxiang of Traditional Chinese Medicine[44] 
and Fatigue Self-Assessment Scale[45], have been used in 
clinical research funded by the Research Fund for the Control 
of Infectious Diseases (Hong Kong SAR Government)[2], 
863 Program[20], State Science and Technology Support 
Program[8,10], National Scientific and Technological 
Project[12], NSFC[14-16], Specialized Research Fund for the 
Doctoral Program of Higher Education of China[8,10] and 
Scientific Research Fund of Hunan Provincial Health 
Department of Traditional Chinese Medicine[11]. (5) To 
be translated and indexed in international databases. For 
example, the ChQOL instrument has been translated into 
an English version[46], Australian English version, Italian 
version[47] and traditional Chinese version (Hong Kong)[48], 
and indexed by the Canadian IN-CAM Outcomes Database 
with full-text download provided.
3.3  Other instrument application in clinical research 
of Chinese medicine
Over 150 instruments were used in 2 152 journal articles, 
including general instruments and disease/condition-
specific instruments. Forty-nine of these instruments were 
cited by more than 10 studies (0.5%). They are as follows 
(sorted by percentage sizes): Hamilton Depression Rating 
Scale (n=397, 18.4%), Mini-mental State Examination 
(n=218, 10.1%), Activity of Daily Living Scale (n=188, 
8.7%), Various Visual Analogue Scale (n=162, 7.5%), 
Self-rating Depression Scale (n=145, 6.7%), the Short 
Form 36 Health Survey (SF-36) (n=128, 5.9%), Treatment 
Emergent Symptoms Scale (n=128, 5.9%), Hamilton 
Anxiety Scale (HAMA) (n=113, 5.3%), Self-rating Anxiety 
Scale (n=110, 5.1%), McGill Pain Questionnaire (n=99, 
4.6%), Pittsburgh Sleep Quality Index (n=95, 4.4%), 
Hasegawa Dementia Scale (HDS) (n=94, 4.4%), Regulated 
HDS (n=92, 4.3%), Ashworth Scale (n=60, 2.8%), 
National Institutes of Health Stroke Scale (n=56, 2.6%), 
Barthel Index (n=52, 2.4%), Clinical Global Impression Scale 
(n=44, 2.0%), Symptom Checklist 90 (n=40, 1.9%), the 
World Health Organization Quality of Life (WHOQOL)-
BREF (n=37, 1.7%), Fatigue Scale-14 (n=34, 1.6%), 
Western Ontario and McMaster Universities Osteoarthritis 
Index (n=29, 1.3%), Fugl-Meyer Assessment (n=29, 
1.3%), Rating Scale for Side Effects (n=29, 1.3%), 
Blessed Behavioral Scale (n=26, 1.2%), Neck Pain 
Questionnaire (n=23, 1.1%), Functional Activities 
Questionnaire (n=23, 1.1%), House Brackmann Grading 
Scale (n=22, 1.0%), Athens Insomnia Scale (n=20, 1.0%), 
Functional Assessment of Cancer Therapy (FACT) Series 
Scales (n=19, 0.8%), Scandinavian Stroke Scale (n=18, 
0.8%), Brief Psychiatric Rating Scale (n=16, 0.8%), 
Neurological Deficit Scale (n=14, 0.7%), Chinese Stroke 
Scale (n=14, 0.7%), Modified Barthel Index (n=14, 0.7%), 
Clinical Memory Scale (n=13, 0.6%), Montreal Cognitive 
Scale (n=13, 0.6%), Yale Global Tie Severity Scale (n=13, 
0.6%), Gross Motor Function Measure (n=13, 0.6%), 
Simplified McGill Pain Questionnaire (n=12, 0.6%), 
Clinician-administered Scale for DSM-IV (n=12, 0.6%), 
Karnofsky Performance Scale (KPS) (n=12, 0.6%), Seattle 
Angina Questionnaire (n=12, 0.6%), Cervical Vertigo 
Symptoms and Functional Assessment Scales (n=12, 
0.6%), Sleep Dysfunction Rating Scale (n=11, 0.5%), 
Clinic Spasticity Index (n=11, 0.5%), Numerical Rating 
Scale (n=11, 0.5%), Wechsler Memory Scale (n=10, 
0.5%), the Spiegel Score (n=10, 0.5%) and GESELL 
(n=10, 0.5%). In addition, 53 instruments were used in 
2 to 9 studies. The remaining instruments were used by 
only one study. The analyses above did not include the 
97 domestic instruments in Chinese medicine.
However, most of these instruments mentioned above 
were developed in Western settings, only a few of them 
were domestically developed, such as the Chinese Quality of 
Life Instrument for Cancer[49]. Only a few of studies such 
as the Rhinoconjunctivitis Quality of Life Questionnaire 
mentioned obtaining rights for accessing the original 
instrument[50]. Although the data of the vast majority of 
instruments were appropriately analyzed, many self-
developed instruments did not perform a property assessment, 
such as the Postpartum Prolactin Self-protection Capabilities 
Assessment Scale[51] and Post Stroke Depression Treated 
with Acupuncture Assessment Scale[52]. Moreover, many 
instruments were used for outcome assessment; only a 
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minority (about 4%) were used as primary outcomes in 
the results[53].
4  Discussion
4.1  Characteristics of instrument application
Chinese medicine instruments have the following char-
acteristics in clinical application. First, health assessment 
instruments in Chinese medicine have been applied in 
numerous novel ways, in both clinical and scientific 
settings. These questionnaires were used in studies 
with various designs, including cross-sectional survey, 
descriptive study and prognosis research; they covered 
internal, surgical and gynecological diseases, acute and 
chronic diseases, organic and functional diseases, or 
other pathological conditions. Second, some research 
was performed without language or regional barriers. 
International collaborations in instrument research 
have been increasing rapidly[2,34,54]. Third, application 
of Chinese medicine instruments is increasing yearly, 
which reflects the trend of Chinese medicine researchers’ 
increasingly open and active role in verifying therapeutic 
effects of traditional Chinese medicine. Lastly, although 
over 150 different instruments were used in Chinese medicine 
clinical trials, a few instruments such as WHOQOL-BREF, 
HAMA, SF-36 and KPS had much more widespread usage. 
This shows that the main research directions are fairly stable. 
4.2  Limitations of instrument application
Some limitations still exist in instrument application. 
(1) Lack of rationale for instrument selection. Only a 
few researchers described the reasons for instrument 
selection which is a crucial step in application research 
since inappropriate instrument selection may lead to false-
positive or false-negative results, or may unnecessarily 
increase research burden. (2) Design defects. Most of the 
clinical trials were poorly designed. For example, many 
randomized controlled trials did not clearly describe the 
randomization, allocation concealment, blinding method, 
and comparison and placebos. The methodology and 
reporting were poorly performed, and consequently had 
unreliable results. (3) Unclear outcome selection. Clinical 
outcomes should reflect the efficacy and safety of inter-
ventions, but many selected outcomes in the studies could 
not achieve this aim. Moreover, many researchers used 
instruments as secondary outcomes, and preferred foreign 
instruments without explanations on endpoint model and 
instrument equivalence. (4) Poor result explanations. Few 
instruments in Chinese medicine established a normal 
model for clinical practice and result explanations. 
Researchers could only estimate their intervention 
according to the changes in the scores before and after 
treatment, but could not clearly explain cross-sectional 
scores, which limited the application of the instruments. 
(5) Low-level standardization. Very few studies included 
sufficient details or reached standards in their reporting. 
Some published studies have outlined appropriate ways 
to report instrument applications. Although no official 
standards yet exist, many details which have already been 
covered in the current research can provide necessary 
parameters on future instrument research. (6) Unrelated 
instrument development and application. Currently, many 
Chinese medicine clinical trials are using instruments 
developed in other countries, for example, from Western 
cultures, rather than those developed under the specific 
theoretical framework of traditional Chinese medicine, 
which would be a lot more applicable and relevant to Chinese 
medicine clinical trials. This is an inefficient use of scientific 
resources.
4.3  Causes of limitations
Limitations of instrument application research in Chinese 
medicine mentioned above may be due to the following 
reasons. (1) Lack of guidance from academic organizations 
and support from the government. Currently, many 
excellent foreign academic organizations and government 
sectors are involved in health outcome research, including 
the International Society for Quality of Life Research 
(ISOQOL), European Regulatory Issues on Quality of 
Life Assessment Group, Patient-Reported Outcomes 
Harmonization Group, Mapi Research Institute and the 
US Food and Drug Administration. Their financial and 
scientific assets greatly propel the research progress of 
instrument development; there is a constant, consistent 
stream of exploration and publication of new findings. 
In contrast, similar institutions do not exist yet in China. 
(2) Lack of independent and rigorous research guidance. 
Although many global guidelines have been developed, 
most of them were established on the premises of Western 
culture and their own clinical and research practices. 
Compared with Western medicine, Chinese medicine 
clinical trials have some distinct characteristics, so 
blindly replicating Western research specifications may 
not provide accurate or complete results. (3) Lack of 
scientific data and media platform. This kind of platform 
would integrate academic resources, greatly facilitate 
the retrieval and judgment of the researchers or patients, 
and promote strong professional research development. 
PubMed, Patient-Reported Outcome and Quality of Life 
Instruments Database, Quality of Life Research, etc., have 
good operability in practical applications. At present, all 
domestic databases have different literature sources and 
retrieval features, which are inconvenient to access, and 
to a certain extent, hinder communication. Therefore, 
a national data platform is urgently needed. (4) Poor 
communication with the public result in undesirable 
numbers in target populations. Not all patients, clinicians 
or even researchers clearly understand which instruments 
can best reflect the target health status, hence instrument 
usage does not reach its full potential. (5) Lack of multi-
www.jcimjournal.com/jim
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center cooperation and collaborations under different 
administrative regions, cultural backgrounds, languages, 
medical institution levels and disciplines.
4.4  Countermeasures for limitations
To solve these problems, the research groups and many 
instrument experts, clinicians and statisticians together 
have made many changes. In May 2008, a group of 
13 ISOQOL members from Mainland China, Hong Kong 
and Taiwan established the ISOQOL-Asian Chinese 
Chapter (ISOQOL-ACC) in Guangzhou, China. Its aim 
was to promote sharing, collaboration, and education 
among QOL researchers in the Chinese speaking regions, 
to encourage discussion and studies on Chinese culture 
and language-specific issues related to QOL researchers, 
and to connect QOL researchers in the Chinese speaking 
regions to the rest of the world[55]. The research group 
has held many conferences and training courses. As 
of this date, five national QOL academic conferences 
and three ISOQOL-ACC symposiums were held in 
the years 2000, 2002, 2004, 2008, 2010 and 2012. 
These academic conferences focused on instrument 
development and cross-cultural adaptation, methodology, 
clinical trials design, analysis and reporting, outcome 
assessment, Chinese medicine and Chinese culture. After 
several rounds of expert discussions, inclusion of the 
latest research findings both domestically and abroad, 
and several amendments, the draft of Guidelines for 
Medical Instrument Development and Application[56] was 
published in 2010. The guidelines detailed several aspects, 
such as the concept and classification of instruments, 
rationale, developments, applications, clinical practice, 
cross-cultural adaptation and statistical analysis. It also 
illustrated the development and evaluation processes of 
ChQOL instrument and a Chinese version of WHOQOL. 
The Preferred Reporting Items for Patient-Reported 
Outcome Instrument Development (PRIPROID) has 
been preliminarily drafted[57]. PRIPROID, including 23 items 
of 7 domains, was proposed to provide reference for 
instrument development reporting. Essentially, a Chinese 
medicine instrument is a representation of Chinese culture 
and should not be limited by different medical systems in 
practice. Thus, we recommend that the Chinese instrument 
research should abandon differences between Chinese and 
Western medicine and specificities of various regions, and 
instead further explore instrument development that is 
suitable across different cultural and medical systems[58].
However, these efforts are still inadequate for the ideal 
scenario of further research development. Much more 
support, collaboration and communication is still needed, 
which may be achieved by: (1) strengthening national 
academic cooperation by establishing academic sub-groups, 
for example, on methodology and clinical medicine, and 
actively introducing new international academic notions, 
so that rigorous critical academic thinking may be better 
practiced among researchers of QOL; (2) establishing 
an integrated scientific research data and media platform 
on instrument research to provide a good venue for data 
integration and information dissemination; (3) seeking 
more government support in promoting popularization, 
education and application of instrument research; 
(4) enhancing theoretical and fundamental research with 
clear definitions on basic concepts and terminology to 
standardize instrument research; (5) improving studies 
on cross-medicinal and cross-cultural instruments and 
the state and role of Chinese medicine instruments; 
(6) more communication and cooperation with statistics, 
psychology, sociology and other disciplines, so that new 
ideas, methods and ways of thinking can be introduced 
into the field of instrument research.
4.5  Advantages, limitations and value of this study
4.5.1  Advantages
We analyzed Chinese medicine instrument development 
and application research with independent search 
strategies. The study procedure was strictly controlled, 
and included data extraction and analyses. Analyses were 
prudently and rigorously performed. Thus, we believe our 
conclusions are logical and reasonably reliable.
4.5.2  Limitations
Some limitations exist in our research. (1) The search 
strategies were not completely comprehensive. First, 
we limited our search to Chinese medicine, integrated 
traditional Chinese and Western medicine, Chinese 
pharmacology sub-categories or a CLC number of R2 
(Chinese Library Classification: Chinese medicine) in 
CNKI. The literature included may not have reflected all 
progress in academic research. Second, being limited by 
the classification of each database, the domain definition 
may have excluded some studies in Chinese medicine, 
which may have left some Chinese medicine instruments 
unidentified. In the research of instrument application, the 
literature was only sourced from CNKI, which again may 
have left out important information because CNKI does 
not collects all published documents. (2) Due to space 
limitations, much information collected by data extraction 
table was not listed, which may affect the quality 
evaluation of the conclusion.
However, we believe that these limitations did not 
impact our conclusions in any significant manner. First, 
the databases mentioned above have included the vast 
majority of eligible journals and all the core journals in 
Chinese medicine, thus they should at least truly reflect 
current main trends of instrument research in Chinese 
medicine. Second, although some Chinese medicine 
research was not included, supplementary searches found 
that the most of the excluded research was overlapped 
in the retrieval results and no high-quality instrument 
was missing. Retrieving results of instrument application 
research in a single database may have narrowed the 
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number of literature results. However, the 2 152 filtered 
records used in this study were independently screened 
from the original 4 557 records by two researchers. This 
should therefore increase the likelihood that the search 
result was credible and typical. Last but not least, although 
some of the data were not listed, vital information for 
assessment instrument development and application have 
been provided, so readers can easily track down the results 
themselves by contacting our research group.
4.5.3  Value of this study
Being of a theoretical nature, the clinical value of this 
study is limited. Our main purpose is to provide a list of 
assessment instruments to choose from and recommend 
options that clinicians can use to expand their horizons while 
evaluating outcomes. The theoretical significance of this 
study is to systematically display the current situation of 
development and application of QOL assessment instruments 
in Chinese medicine for the very first time, from which 
researchers can understand, analyze and evaluate domestic-
related research. We also analyzed the current limitations in 
instrument research and the countermeasures that can provide 
the basis for generating sustainable development strategies of 
assessment instrument research.
5  Conclusions 
Due to the complexity in details of assessment instrument 
development and application, and unavoidable subjective 
factors during the process of retrieval and screening, 
the results of this article may not completely represent 
the current state of domestic assessment instrument 
development and application; further studies with more 
rigorous methodologies are needed. At present, a limited 
amount of data show that domestic research in the 
development and application of assessment instruments 
in Chinese medicine are developing rapidly. However, 
there are still shortcomings in the domains of conceptual 
framework, study process, attribute evaluation, statistics, 
application basis, study designation, result analysis and 
standardization, etc. These limitations are affected by 
various factors and resolving them will be a complex, 
long-term process requiring interdisciplinary efforts 
between different academic, media, and governmental 
organizations, and even across different nations. Many 
excellent researchers and clinicians have already made 
significant contributions in this field. Research on the 
QOL assessment instruments in Chinese medicine will 
play an important role in the never-ending mission to 
improve human health.
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